Literature DB >> 17006941

An autoimmune biliary disease mouse model for primary biliary cirrhosis: something for everyone.

Andrew L Mason1.   

Abstract

Entities:  

Year:  2006        PMID： 17006941     DOI： 10.1002/hep.21390

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  The genetic study of primary biliary cirrhosis: great hope, some caution.

Authors:  Gideon M Hirschfield; E J Heathcote
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 3.  Combination antiretroviral studies for patients with primary biliary cirrhosis.

Authors:  Ellina Lytvyak; Aldo J Montano-Loza; Andrew L Mason
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

5.  Role of novel retroviruses in chronic liver disease: assessing the link of human betaretrovirus with primary biliary cirrhosis.

Authors:  David Sharon; Andrew L Mason
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

Review 6.  Rodent models of cholestatic liver disease: A practical guide for translational research.

Authors:  Eva Gijbels; Alanah Pieters; Kevin De Muynck; Mathieu Vinken; Lindsey Devisscher
Journal:  Liver Int       Date:  2021-02-23       Impact factor: 5.828

7.  Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.

Authors:  David Sharon; Min Chen; Guangzhi Zhang; Safwat Girgis; Banu Sis; Don Graham; Chelsea McDougall; Shawn T Wasilenko; Aldo Montano-Loza; Andrew L Mason
Journal:  Liver Int       Date:  2014-10-31       Impact factor: 5.828
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.